• レポートコード:QY2108PAL8913 • 出版社/出版日:QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、157ページ • 納品方法:Eメール(納期:1日) • 産業分類:医薬品 |
Single User | ¥585,000 (USD3,900) | ▷ お問い合わせ |
Multi User | ¥877,500 (USD5,850) | ▷ お問い合わせ |
Enterprise License | ¥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の当調査資料ではグローバルにおける医薬品中間体の市場規模(2016年-2027年)と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、医薬品中間体の種類別市場規模(GMP、非GMP)、用途別市場規模(抗生物質、解熱鎮痛薬、ビタミン、その他)も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界の医薬品中間体市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界における医薬品中間体の種類別市場規模(2016年-2027年):GMP、非GMP ・世界における医薬品中間体の用途別市場規模(2016年-2027年):抗生物質、解熱鎮痛薬、ビタミン、その他 ・医薬品中間体の中国市場分析 - 医薬品中間体の中国市場規模(2016年-2027年) - 中国における医薬品中間体の主要プレイヤー別市場シェア - 中国における医薬品中間体の種類別市場規模:GMP、非GMP - 中国における医薬品中間体の用途別市場規模:抗生物質、解熱鎮痛薬、ビタミン、その他 ・医薬品中間体の北米市場(2016年-2027年) ・医薬品中間体のヨーロッパ市場(2016年-2027年) ・医薬品中間体のアジア太平洋市場(2016年-2027年) ・医薬品中間体の中南米市場(2016年-2027年) ・医薬品中間体の中東・アフリカ市場(2016年-2027年) ・主要プレイヤーの情報:Lonza、Catalent、Patheon、Jubilant、Granules、Ganesh、Chemcon、BASF、Porton、Lianhetech、ABA Chem、Tianma、Jiujiujiu、Alpha、Jiuzhou、Yongtai ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Global Pharmaceutical Intermediates key players include Wartsila, Hyundai, MAN, MES, Caterpillar, etc. Global top three manufacturers hold a share over 45%.
China is the largest production area, with a share about 30%, followed by India and North America, both have a share over 40 percent.
In terms of product, GMP is the largest segment, with a share over 80%. And in terms of application, the largest application is Antibiotics, followed by Antipyretic analgesics, etc.
Market Analysis and Insights: Global and China Pharmaceutical Intermediates Market
This report focuses on global and China Pharmaceutical Intermediates market.
In 2020, the global Pharmaceutical Intermediates market size was US$ 171210 million and it is expected to reach US$ 262730 million by the end of 2027, with a CAGR of 6.3% during 2021-2027. In China the Pharmaceutical Intermediates market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Pharmaceutical Intermediates Scope and Market Size
Pharmaceutical Intermediates market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Pharmaceutical Intermediates market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Pharmaceutical Intermediates market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
GMP
Non-GMP
Segment by Application
Antibiotics
Antipyretic Analgesics
Vitamins
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Lonza
Catalent
Patheon
Jubilant
Granules
Ganesh
Chemcon
BASF
Porton
Lianhetech
ABA Chem
Tianma
Jiujiujiu
Alpha
Jiuzhou
Yongtai
1 Study Coverage
1.1 Pharmaceutical Intermediates Product Introduction
1.2 Market by Type
1.2.1 Global Pharmaceutical Intermediates Market Size Growth Rate by Type
1.2.2 GMP
1.2.3 Non-GMP
1.3 Market by Application
1.3.1 Global Pharmaceutical Intermediates Market Size Growth Rate by Application
1.3.2 Antibiotics
1.3.3 Antipyretic Analgesics
1.3.4 Vitamins
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pharmaceutical Intermediates Market Size, Estimates and Forecasts
2.1.1 Global Pharmaceutical Intermediates Revenue 2016-2027
2.1.2 Global Pharmaceutical Intermediates Sales 2016-2027
2.2 Global Pharmaceutical Intermediates, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Pharmaceutical Intermediates Historical Market Size by Region (2016-2021)
2.3.1 Global Pharmaceutical Intermediates Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Pharmaceutical Intermediates Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Pharmaceutical Intermediates Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Pharmaceutical Intermediates Sales Forecast by Region (2022-2027)
2.4.2 Global Pharmaceutical Intermediates Revenue Forecast by Region (2022-2027)
3 Global Pharmaceutical Intermediates Competitor Landscape by Players
3.1 Global Top Pharmaceutical Intermediates Manufacturers by Sales
3.1.1 Global Pharmaceutical Intermediates Sales by Manufacturer (2016-2021)
3.1.2 Global Pharmaceutical Intermediates Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Pharmaceutical Intermediates Manufacturers by Revenue
3.2.1 Key Pharmaceutical Intermediates Manufacturers Covered: Ranking by Revenue
3.2.2 Global Pharmaceutical Intermediates Revenue by Manufacturers (2016-2021)
3.2.3 Global Pharmaceutical Intermediates Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Pharmaceutical Intermediates Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Pharmaceutical Intermediates Revenue in 2020
3.2.6 Global Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Pharmaceutical Intermediates Price by Manufacturers
3.4 Global Pharmaceutical Intermediates Manufacturing Base Distribution, Product Types
3.4.1 Pharmaceutical Intermediates Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pharmaceutical Intermediates Product Type
3.4.3 Date of International Manufacturers Enter into Pharmaceutical Intermediates Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Pharmaceutical Intermediates Market Size by Type (2016-2021)
4.1.1 Global Pharmaceutical Intermediates Sales by Type (2016-2021)
4.1.2 Global Pharmaceutical Intermediates Revenue by Type (2016-2021)
4.1.3 Pharmaceutical Intermediates Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Pharmaceutical Intermediates Market Size Forecast by Type (2022-2027)
4.2.1 Global Pharmaceutical Intermediates Sales Forecast by Type (2022-2027)
4.2.2 Global Pharmaceutical Intermediates Revenue Forecast by Type (2022-2027)
4.2.3 Pharmaceutical Intermediates Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Pharmaceutical Intermediates Market Size by Application (2016-2021)
5.1.1 Global Pharmaceutical Intermediates Sales by Application (2016-2021)
5.1.2 Global Pharmaceutical Intermediates Revenue by Application (2016-2021)
5.1.3 Pharmaceutical Intermediates Price by Application (2016-2021)
5.2 Pharmaceutical Intermediates Market Size Forecast by Application (2022-2027)
5.2.1 Global Pharmaceutical Intermediates Sales Forecast by Application (2022-2027)
5.2.2 Global Pharmaceutical Intermediates Revenue Forecast by Application (2022-2027)
5.2.3 Global Pharmaceutical Intermediates Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Pharmaceutical Intermediates Market Size YoY Growth 2016-2027
6.1.1 China Pharmaceutical Intermediates Sales YoY Growth 2016-2027
6.1.2 China Pharmaceutical Intermediates Revenue YoY Growth 2016-2027
6.1.3 China Pharmaceutical Intermediates Market Share in Global Market 2016-2027
6.2 China Pharmaceutical Intermediates Market Size by Players (International and Local Players)
6.2.1 China Top Pharmaceutical Intermediates Players by Sales (2016-2021)
6.2.2 China Top Pharmaceutical Intermediates Players by Revenue (2016-2021)
6.3 China Pharmaceutical Intermediates Historic Market Review by Type (2016-2021)
6.3.1 China Pharmaceutical Intermediates Sales Market Share by Type (2016-2021)
6.3.2 China Pharmaceutical Intermediates Revenue Market Share by Type (2016-2021)
6.3.3 China Pharmaceutical Intermediates Price by Type (2016-2021)
6.4 China Pharmaceutical Intermediates Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Pharmaceutical Intermediates Sales Forecast by Type (2022-2027)
6.4.2 China Pharmaceutical Intermediates Revenue Forecast by Type (2022-2027)
6.4.3 China Pharmaceutical Intermediates Price Forecast by Type (2022-2027)
6.5 China Pharmaceutical Intermediates Historic Market Review by Application (2016-2021)
6.5.1 China Pharmaceutical Intermediates Sales Market Share by Application (2016-2021)
6.5.2 China Pharmaceutical Intermediates Revenue Market Share by Application (2016-2021)
6.5.3 China Pharmaceutical Intermediates Price by Application (2016-2021)
6.6 China Pharmaceutical Intermediates Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Pharmaceutical Intermediates Sales Forecast by Application (2022-2027)
6.6.2 China Pharmaceutical Intermediates Revenue Forecast by Application (2022-2027)
6.6.3 China Pharmaceutical Intermediates Price Forecast by Application (2022-2027)
7 North America
7.1 North America Pharmaceutical Intermediates Market Size YoY Growth 2016-2027
7.2 North America Pharmaceutical Intermediates Market Facts & Figures by Country
7.2.1 North America Pharmaceutical Intermediates Sales by Country (2016-2021)
7.2.2 North America Pharmaceutical Intermediates Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Pharmaceutical Intermediates Market Size YoY Growth 2016-2027
8.2 Asia Pacific Pharmaceutical Intermediates Market Facts & Figures by Region
8.2.1 Asia Pacific Pharmaceutical Intermediates Sales by Region (2016-2021)
8.2.2 Asia Pacific Pharmaceutical Intermediates Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Pharmaceutical Intermediates Market Size YoY Growth 2016-2027
9.2 Europe Pharmaceutical Intermediates Market Facts & Figures by Country
9.2.1 Europe Pharmaceutical Intermediates Sales by Country (2016-2021)
9.2.2 Europe Pharmaceutical Intermediates Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Pharmaceutical Intermediates Market Size YoY Growth 2016-2027
10.2 Latin America Pharmaceutical Intermediates Market Facts & Figures by Country
10.2.1 Latin America Pharmaceutical Intermediates Sales by Country (2016-2021)
10.2.2 Latin America Pharmaceutical Intermediates Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Pharmaceutical Intermediates Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Pharmaceutical Intermediates Market Facts & Figures by Country
11.2.1 Middle East and Africa Pharmaceutical Intermediates Sales by Country (2016-2021)
11.2.2 Middle East and Africa Pharmaceutical Intermediates Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Lonza
12.1.1 Lonza Corporation Information
12.1.2 Lonza Description and Business Overview
12.1.3 Lonza Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Lonza Pharmaceutical Intermediates Products Offered
12.1.5 Lonza Recent Development
12.2 Catalent
12.2.1 Catalent Corporation Information
12.2.2 Catalent Description and Business Overview
12.2.3 Catalent Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Catalent Pharmaceutical Intermediates Products Offered
12.2.5 Catalent Recent Development
12.3 Patheon
12.3.1 Patheon Corporation Information
12.3.2 Patheon Description and Business Overview
12.3.3 Patheon Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Patheon Pharmaceutical Intermediates Products Offered
12.3.5 Patheon Recent Development
12.4 Jubilant
12.4.1 Jubilant Corporation Information
12.4.2 Jubilant Description and Business Overview
12.4.3 Jubilant Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Jubilant Pharmaceutical Intermediates Products Offered
12.4.5 Jubilant Recent Development
12.5 Granules
12.5.1 Granules Corporation Information
12.5.2 Granules Description and Business Overview
12.5.3 Granules Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Granules Pharmaceutical Intermediates Products Offered
12.5.5 Granules Recent Development
12.6 Ganesh
12.6.1 Ganesh Corporation Information
12.6.2 Ganesh Description and Business Overview
12.6.3 Ganesh Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Ganesh Pharmaceutical Intermediates Products Offered
12.6.5 Ganesh Recent Development
12.7 Chemcon
12.7.1 Chemcon Corporation Information
12.7.2 Chemcon Description and Business Overview
12.7.3 Chemcon Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Chemcon Pharmaceutical Intermediates Products Offered
12.7.5 Chemcon Recent Development
12.8 BASF
12.8.1 BASF Corporation Information
12.8.2 BASF Description and Business Overview
12.8.3 BASF Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.8.4 BASF Pharmaceutical Intermediates Products Offered
12.8.5 BASF Recent Development
12.9 Porton
12.9.1 Porton Corporation Information
12.9.2 Porton Description and Business Overview
12.9.3 Porton Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Porton Pharmaceutical Intermediates Products Offered
12.9.5 Porton Recent Development
12.10 Lianhetech
12.10.1 Lianhetech Corporation Information
12.10.2 Lianhetech Description and Business Overview
12.10.3 Lianhetech Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Lianhetech Pharmaceutical Intermediates Products Offered
12.10.5 Lianhetech Recent Development
12.11 Lonza
12.11.1 Lonza Corporation Information
12.11.2 Lonza Description and Business Overview
12.11.3 Lonza Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Lonza Pharmaceutical Intermediates Products Offered
12.11.5 Lonza Recent Development
12.12 Tianma
12.12.1 Tianma Corporation Information
12.12.2 Tianma Description and Business Overview
12.12.3 Tianma Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Tianma Products Offered
12.12.5 Tianma Recent Development
12.13 Jiujiujiu
12.13.1 Jiujiujiu Corporation Information
12.13.2 Jiujiujiu Description and Business Overview
12.13.3 Jiujiujiu Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Jiujiujiu Products Offered
12.13.5 Jiujiujiu Recent Development
12.14 Alpha
12.14.1 Alpha Corporation Information
12.14.2 Alpha Description and Business Overview
12.14.3 Alpha Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Alpha Products Offered
12.14.5 Alpha Recent Development
12.15 Jiuzhou
12.15.1 Jiuzhou Corporation Information
12.15.2 Jiuzhou Description and Business Overview
12.15.3 Jiuzhou Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Jiuzhou Products Offered
12.15.5 Jiuzhou Recent Development
12.16 Yongtai
12.16.1 Yongtai Corporation Information
12.16.2 Yongtai Description and Business Overview
12.16.3 Yongtai Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Yongtai Products Offered
12.16.5 Yongtai Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Pharmaceutical Intermediates Industry Trends
13.2 Pharmaceutical Intermediates Market Drivers
13.3 Pharmaceutical Intermediates Market Challenges
13.4 Pharmaceutical Intermediates Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pharmaceutical Intermediates Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Pharmaceutical Intermediates Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of GMP
Table 3. Major Manufacturers of Non-GMP
Table 4. Global Pharmaceutical Intermediates Market Size Growth Rate by Application (2021-2027) & (K MT)
Table 5. Global Pharmaceutical Intermediates Market Size by Region (K MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Pharmaceutical Intermediates Sales by Regions (2016-2021) & (K MT)
Table 7. Global Pharmaceutical Intermediates Sales Market Share by Regions (2016-2021)
Table 8. Global Pharmaceutical Intermediates Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Pharmaceutical Intermediates Sales Forecast by Region (2022-2027) & (K MT)
Table 10. Global Pharmaceutical Intermediates Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Pharmaceutical Intermediates Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Pharmaceutical Intermediates Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Pharmaceutical Intermediates Sales by Manufacturers (2016-2021) (K MT)
Table 14. Global Pharmaceutical Intermediates Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Pharmaceutical Intermediates Manufacturers by Revenue (US$ Million) in 2020
Table 16. Pharmaceutical Intermediates Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Pharmaceutical Intermediates Revenue Share by Manufacturers (2016-2021)
Table 18. Global Pharmaceutical Intermediates Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Pharmaceutical Intermediates by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Intermediates as of 2020)
Table 20. Key Manufacturers Pharmaceutical Intermediates Price (2016-2021) (USD/MT)
Table 21. Pharmaceutical Intermediates Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Pharmaceutical Intermediates Product Type
Table 23. Date of International Manufacturers Enter into Pharmaceutical Intermediates Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Pharmaceutical Intermediates Sales by Type (2016-2021) (K MT)
Table 26. Global Pharmaceutical Intermediates Sales Share by Type (2016-2021)
Table 27. Global Pharmaceutical Intermediates Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Pharmaceutical Intermediates Revenue Share by Type (2016-2021)
Table 29. Pharmaceutical Intermediates Average Selling Price (ASP) by Type (2016-2021) & (USD/MT)
Table 30. Global Pharmaceutical Intermediates Sales Forecast by Type (2022-2027) & (K MT)
Table 31. Global Pharmaceutical Intermediates Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Pharmaceutical Intermediates Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Pharmaceutical Intermediates Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Pharmaceutical Intermediates Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT)
Table 35. Global Pharmaceutical Intermediates Sales by Application (2016-2021) (K MT)
Table 36. Global Pharmaceutical Intermediates Sales Share by Application (2016-2021)
Table 37. Global Pharmaceutical Intermediates Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Pharmaceutical Intermediates Revenue Share by Application (2016-2021)
Table 39. Pharmaceutical Intermediates Average Selling Price (ASP) by Application (2016-2021) & (USD/MT)
Table 40. Global Pharmaceutical Intermediates Sales Forecast by Application (2022-2027) & (K MT)
Table 41. Global Pharmaceutical Intermediates Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Pharmaceutical Intermediates Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Pharmaceutical Intermediates Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Pharmaceutical Intermediates Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT)
Table 45. China Pharmaceutical Intermediates Sales (K MT) of Key Companies (2016-2021)
Table 46. China Pharmaceutical Intermediates Sales Share by Company (2016-2021)
Table 47. China Pharmaceutical Intermediates Revenue (US$ Million) by Company (2016-2021)
Table 48. China Pharmaceutical Intermediates Revenue Share by Company (2016-2021)
Table 49. China Pharmaceutical Intermediates Sales (K MT) by Type (2016-2021)
Table 50. China Pharmaceutical Intermediates Sales Share by Type (2016-2021)
Table 51. China Pharmaceutical Intermediates Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Pharmaceutical Intermediates Price (USD/MT) by Type (2016-2021)
Table 53. China Pharmaceutical Intermediates Sales (K MT) by Type (2022-2027)
Table 54. China Pharmaceutical Intermediates Sales Share by Type (2022-2027)
Table 55. China Pharmaceutical Intermediates Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Pharmaceutical Intermediates Revenue Share by Type (2022-2027)
Table 57. China Pharmaceutical Intermediates Price (USD/MT) by Type (2022-2027)
Table 58. China Pharmaceutical Intermediates Sales (K MT) by Application (2016-2021)
Table 59. China Pharmaceutical Intermediates Sales Share by Application (2016-2021)
Table 60. China Pharmaceutical Intermediates Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Pharmaceutical Intermediates Price (USD/MT) by Application (2016-2021)
Table 62. China Pharmaceutical Intermediates Sales (K MT) by Application (2022-2027)
Table 63. China Pharmaceutical Intermediates Sales Share by Application (2022-2027)
Table 64. China Pharmaceutical Intermediates Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Pharmaceutical Intermediates Revenue Share by Application (2022-2027)
Table 66. China Pharmaceutical Intermediates Price (USD/MT) by Application (2022-2027)
Table 67. North America Pharmaceutical Intermediates Sales by Country (2016-2021) & (K MT)
Table 68. North America Pharmaceutical Intermediates Sales Market Share by Country (2016-2021)
Table 69. North America Pharmaceutical Intermediates Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Pharmaceutical Intermediates Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Pharmaceutical Intermediates Sales by Region (2016-2021) & (K MT)
Table 72. Asia Pacific Pharmaceutical Intermediates Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Pharmaceutical Intermediates Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Pharmaceutical Intermediates Revenue Market Share by Region (2016-2021)
Table 75. Europe Pharmaceutical Intermediates Sales by Country (2016-2021) & (K MT)
Table 76. Europe Pharmaceutical Intermediates Sales Market Share by Country (2016-2021)
Table 77. Europe Pharmaceutical Intermediates Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Pharmaceutical Intermediates Revenue Market Share by Country (2016-2021)
Table 79. Latin America Pharmaceutical Intermediates Sales by Country (2016-2021) & (K MT)
Table 80. Latin America Pharmaceutical Intermediates Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Pharmaceutical Intermediates Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Pharmaceutical Intermediates Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Pharmaceutical Intermediates Sales by Country (2016-2021) & (K MT)
Table 84. Middle East and Africa Pharmaceutical Intermediates Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Pharmaceutical Intermediates Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Pharmaceutical Intermediates Revenue Market Share by Country (2016-2021)
Table 87. Lonza Corporation Information
Table 88. Lonza Description and Business Overview
Table 89. Lonza Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 90. Lonza Pharmaceutical Intermediates Product
Table 91. Lonza Recent Development
Table 92. Catalent Corporation Information
Table 93. Catalent Description and Business Overview
Table 94. Catalent Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 95. Catalent Product
Table 96. Catalent Recent Development
Table 97. Patheon Corporation Information
Table 98. Patheon Description and Business Overview
Table 99. Patheon Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 100. Patheon Product
Table 101. Patheon Recent Development
Table 102. Jubilant Corporation Information
Table 103. Jubilant Description and Business Overview
Table 104. Jubilant Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 105. Jubilant Product
Table 106. Jubilant Recent Development
Table 107. Granules Corporation Information
Table 108. Granules Description and Business Overview
Table 109. Granules Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 110. Granules Product
Table 111. Granules Recent Development
Table 112. Ganesh Corporation Information
Table 113. Ganesh Description and Business Overview
Table 114. Ganesh Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 115. Ganesh Product
Table 116. Ganesh Recent Development
Table 117. Chemcon Corporation Information
Table 118. Chemcon Description and Business Overview
Table 119. Chemcon Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 120. Chemcon Product
Table 121. Chemcon Recent Development
Table 122. BASF Corporation Information
Table 123. BASF Description and Business Overview
Table 124. BASF Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 125. BASF Product
Table 126. BASF Recent Development
Table 127. Porton Corporation Information
Table 128. Porton Description and Business Overview
Table 129. Porton Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 130. Porton Product
Table 131. Porton Recent Development
Table 132. Lianhetech Corporation Information
Table 133. Lianhetech Description and Business Overview
Table 134. Lianhetech Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 135. Lianhetech Product
Table 136. Lianhetech Recent Development
Table 137. ABA Chem Corporation Information
Table 138. ABA Chem Description and Business Overview
Table 139. ABA Chem Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 140. ABA Chem Product
Table 141. ABA Chem Recent Development
Table 142. Tianma Corporation Information
Table 143. Tianma Description and Business Overview
Table 144. Tianma Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 145. Tianma Product
Table 146. Tianma Recent Development
Table 147. Jiujiujiu Corporation Information
Table 148. Jiujiujiu Description and Business Overview
Table 149. Jiujiujiu Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 150. Jiujiujiu Product
Table 151. Jiujiujiu Recent Development
Table 152. Alpha Corporation Information
Table 153. Alpha Description and Business Overview
Table 154. Alpha Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 155. Alpha Product
Table 156. Alpha Recent Development
Table 157. Jiuzhou Corporation Information
Table 158. Jiuzhou Description and Business Overview
Table 159. Jiuzhou Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 160. Jiuzhou Product
Table 161. Jiuzhou Recent Development
Table 162. Yongtai Corporation Information
Table 163. Yongtai Description and Business Overview
Table 164. Yongtai Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 165. Yongtai Product
Table 166. Yongtai Recent Development
Table 167. Pharmaceutical Intermediates Market Trends
Table 168. Pharmaceutical Intermediates Market Drivers
Table 169. Pharmaceutical Intermediates Market Challenges
Table 170. Pharmaceutical Intermediates Market Restraints
Table 171. Pharmaceutical Intermediates Customers List
Table 172. Pharmaceutical Intermediates Distributors List
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmaceutical Intermediates Product Picture
Figure 2. Global Pharmaceutical Intermediates Sales Market Share by Type in 2020 & 2027
Figure 3. GMP Product Picture
Figure 4. Non-GMP Product Picture
Figure 5. Global Pharmaceutical Intermediates Sales Market Share by Application in 2020 & 2027
Figure 6. Antibiotics
Figure 7. Antipyretic Analgesics
Figure 8. Vitamins
Figure 9. Others
Figure 10. Pharmaceutical Intermediates Report Years Considered
Figure 11. Global Pharmaceutical Intermediates Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Pharmaceutical Intermediates Market Size 2016-2027 (US$ Million)
Figure 13. Global Pharmaceutical Intermediates Sales 2016-2027 (K MT)
Figure 14. Global Pharmaceutical Intermediates Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Pharmaceutical Intermediates Sales Market Share by Region (2016-2021)
Figure 16. Global Pharmaceutical Intermediates Sales Market Share by Region in 2020
Figure 17. Global Pharmaceutical Intermediates Revenue Market Share by Region (2016-2021)
Figure 18. Global Pharmaceutical Intermediates Revenue Market Share by Region in 2020
Figure 19. Global Pharmaceutical Intermediates Sales Share by Manufacturer in 2020
Figure 20. The Top 10 and 5 Players Market Share by Pharmaceutical Intermediates Revenue in 2020
Figure 21. Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Pharmaceutical Intermediates Sales Market Share by Type (2016-2021)
Figure 23. Global Pharmaceutical Intermediates Sales Market Share by Type in 2020
Figure 24. Global Pharmaceutical Intermediates Revenue Market Share by Type (2016-2021)
Figure 25. Global Pharmaceutical Intermediates Revenue Market Share by Type in 2020
Figure 26. Global Pharmaceutical Intermediates Sales Market Share by Application (2016-2021)
Figure 27. Global Pharmaceutical Intermediates Sales Market Share by Application in 2020
Figure 28. Global Pharmaceutical Intermediates Revenue Market Share by Application (2016-2021)
Figure 29. Global Pharmaceutical Intermediates Revenue Market Share by Application in 2020
Figure 30. China Pharmaceutical Intermediates Sales Growth Rate 2016-2027 (K MT)
Figure 31. China Pharmaceutical Intermediates Revenue Growth Rate 2016-2027 (US$ Million)
Figure 32. China Pharmaceutical Intermediates Market Share in Global Market 2016-2027
Figure 33. China 5 and 10 Largest Pharmaceutical Intermediates Players Market Share by Revenue in Pharmaceutical Intermediates in 2020
Figure 34. China Pharmaceutical Intermediates Revenue Share by Type (2016-2021)
Figure 35. China Pharmaceutical Intermediates Revenue Growth Rate by Type in 2016 & 2020
Figure 36. China Pharmaceutical Intermediates Revenue Share by Application (2016-2021)
Figure 37. China Pharmaceutical Intermediates Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Pharmaceutical Intermediates Sales Growth Rate 2016-2021 (K MT)
Figure 39. North America Pharmaceutical Intermediates Revenue Growth Rate 2016-2021 (US$ Million)
Figure 40. North America Pharmaceutical Intermediates Sales Market Share by Country in 2020
Figure 41. North America Pharmaceutical Intermediates Revenue Market Share by Country in 2020
Figure 42. U.S. Pharmaceutical Intermediates Sales Growth Rate (2016-2021) (K MT)
Figure 43. U.S. Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Canada Pharmaceutical Intermediates Sales Growth Rate (2016-2021) (K MT)
Figure 45. Canada Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Europe Pharmaceutical Intermediates Sales Growth Rate 2016-2021 (K MT)
Figure 47. Europe Pharmaceutical Intermediates Revenue Growth Rate 2016-2021 (US$ Million)
Figure 48. Europe Pharmaceutical Intermediates Sales Market Share by Country in 2020
Figure 49. Europe Pharmaceutical Intermediates Revenue Market Share by Country in 2020
Figure 50. Germany Pharmaceutical Intermediates Sales Growth Rate (2016-2021) (K MT)
Figure 51. Germany Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. France Pharmaceutical Intermediates Sales Growth Rate (2016-2021) (K MT)
Figure 53. France Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. U.K. Pharmaceutical Intermediates Sales Growth Rate (2016-2021) (K MT)
Figure 55. U.K. Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Italy Pharmaceutical Intermediates Sales Growth Rate (2016-2021) (K MT)
Figure 57. Italy Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Russia Pharmaceutical Intermediates Sales Growth Rate (2016-2021) (K MT)
Figure 59. Russia Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Asia Pacific Pharmaceutical Intermediates Sales Growth Rate 2016-2021 (K MT)
Figure 61. Asia Pacific Pharmaceutical Intermediates Revenue Growth Rate 2016-2021 (US$ Million)
Figure 62. Asia Pacific Pharmaceutical Intermediates Sales Market Share by Region in 2020
Figure 63. Asia Pacific Pharmaceutical Intermediates Revenue Market Share by Region in 2020
Figure 64. China Pharmaceutical Intermediates Sales Growth Rate (2016-2021) (K MT)
Figure 65. China Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Japan Pharmaceutical Intermediates Sales Growth Rate (2016-2021) (K MT)
Figure 67. Japan Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. South Korea Pharmaceutical Intermediates Sales Growth Rate (2016-2021) (K MT)
Figure 69. South Korea Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. India Pharmaceutical Intermediates Sales Growth Rate (2016-2021) (K MT)
Figure 71. India Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Australia Pharmaceutical Intermediates Sales Growth Rate (2016-2021) (K MT)
Figure 73. Australia Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. China Taiwan Pharmaceutical Intermediates Sales Growth Rate (2016-2021) (K MT)
Figure 75. China Taiwan Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Indonesia Pharmaceutical Intermediates Sales Growth Rate (2016-2021) (K MT)
Figure 77. Indonesia Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Thailand Pharmaceutical Intermediates Sales Growth Rate (2016-2021) (K MT)
Figure 79. Thailand Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Malaysia Pharmaceutical Intermediates Sales Growth Rate (2016-2021) (K MT)
Figure 81. Malaysia Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Latin America Pharmaceutical Intermediates Sales Growth Rate 2016-2021 (K MT)
Figure 83. Latin America Pharmaceutical Intermediates Revenue Growth Rate 2016-2021 (US$ Million)
Figure 84. Latin America Pharmaceutical Intermediates Sales Market Share by Country in 2020
Figure 85. Latin America Pharmaceutical Intermediates Revenue Market Share by Country in 2020
Figure 86. Mexico Pharmaceutical Intermediates Sales Growth Rate (2016-2021) (K MT)
Figure 87. Mexico Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 88. Brazil Pharmaceutical Intermediates Sales Growth Rate (2016-2021) (K MT)
Figure 89. Brazil Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Argentina Pharmaceutical Intermediates Sales Growth Rate (2016-2021) (K MT)
Figure 91. Argentina Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Middle East and Africa Pharmaceutical Intermediates Sales Growth Rate 2016-2021 (K MT)
Figure 93. Middle East and Africa Pharmaceutical Intermediates Revenue Growth Rate 2016-2021 (US$ Million)
Figure 94. Middle East and Africa Pharmaceutical Intermediates Sales Market Share by Country in 2020
Figure 95. Middle East and Africa Pharmaceutical Intermediates Revenue Market Share by Country in 2020
Figure 96. Turkey Pharmaceutical Intermediates Sales Growth Rate (2016-2021) (K MT)
Figure 97. Turkey Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 98. Saudi Arabia Pharmaceutical Intermediates Sales Growth Rate (2016-2021) (K MT)
Figure 99. Saudi Arabia Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. UAE Pharmaceutical Intermediates Sales Growth Rate (2016-2021) (K MT)
Figure 101. UAE Pharmaceutical Intermediates Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. Pharmaceutical Intermediates Value Chain
Figure 103. Channels of Distribution
Figure 104. Distributors Profiles
Figure 105. Bottom-up and Top-down Approaches for This Report
Figure 106. Data Triangulation
Figure 107. Key Executives Interviewed